Literature DB >> 14655874

Down syndrome: interaction between culture, demography, and biology in determining the prevalence of a genetic trait.

Carolyn L Olsen1, Philip K Cross, Lenore J Gensburg.   

Abstract

The incidence of Down syndrome (DS) at conception is highly dependent upon the maternal age distribution and age-specific pregnancy rates. Live-birth prevalence of DS reflects these factors and fetal deaths. Since the introduction of prenatal diagnosis in the early 1970s, the role of fetal deaths in the equation has increased. Between 1920 and the early 1980s, DS live-birth prevalence decreased in many populations due to declining fertility rates, particularly among older women. In the late-1970s the trend reversed, as the median age of populations and birth rates among older women steadily increased. This paper illustrates these interactions using data we have analyzed for New York State (NYS) and comparative data obtained from the literature. Between 1983 and 1997 DS live-birth prevalence in NYS remained stable at about 9.9 per 10,000 live births. The number of prenatal tests performed increased by 158%, and the number of DS fetuses detected prenatally more than quadrupled. Fertility rates of women aged 35-49 continued to increase. The proportion of DS cases born to these older mothers increased from 23% in 1985 to 43% in 1997. We estimated that without prenatal diagnosis, DS live-birth prevalence would have been 17.0 per 10,000 live births by 1995. Cultural factors influence demographic trends, birthing technologies, physician practices, and women's decision-making regarding prenatal screening and diagnosis for DS.

Entities:  

Mesh:

Year:  2003        PMID: 14655874     DOI: 10.1353/hub.2003.0059

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  8 in total

1.  A population-based study of prevalence of Down syndrome in Southern Thailand.

Authors:  Somchit Jaruratanasirikul; Ounjai Kor-Anantakul; Montira Chowvichian; Wannee Limpitikul; Pathikan Dissaneevate; Nitthakarn Intharasangkanawin; Atchara Sattapanyo; Sermsri Pathompanitrat; H Sriplung
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

2.  Live births, natural losses, and elective terminations with Down syndrome in Massachusetts.

Authors:  Gert de Graaf; Frank Buckley; Brian G Skotko
Journal:  Genet Med       Date:  2016-04-14       Impact factor: 8.822

3.  Tracking subtle stereotypes of children with trisomy 21: from facial-feature-based to implicit stereotyping.

Authors:  Claire Enea-Drapeau; Michèle Carlier; Pascal Huguet
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

Review 4.  Oral and craniofacial clinical signs associated to genetic conditions in human identification part I: a review.

Authors:  Fouad Ayoub; Nicole Aoun; Hassan El Husseini; Houssam Jassar; Fida Sayah; Ziad Salameh
Journal:  J Int Oral Health       Date:  2015-05

5.  Pregnancy Outcome following Prenatal Diagnosis of Chromosomal Anomaly: A Record Linkage Study of 26,261 Pregnancies.

Authors:  Myrthe Jacobs; Sally-Ann Cooper; Ruth McGowan; Scott M Nelson; Jill P Pell
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

6.  Demographic Assessment of Down Syndrome: A Systematic Review.

Authors:  Agustín Huete-García; Mónica Otaola-Barranquero
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

7.  Toxoplasma gondii Infection Among Institutionalized Children with Down syndrome in Sana'a city, Yemen: Implications of Low IgG Seroprevalence.

Authors:  Asmaa A H Al-Awadi; Rashad Abdul-Ghani; Abdulsalam M Al-Mekhlafi
Journal:  Acta Parasitol       Date:  2021-10-08       Impact factor: 1.534

8.  Birth incidence, deaths and hospitalisations of children and young people with Down syndrome, 1990-2015: birth cohort study.

Authors:  Laura Anne Hughes-McCormack; Ruth McGowan; J P Pell; Daniel Mackay; Angela Henderson; Lisa O'Leary; Sally-Ann Cooper
Journal:  BMJ Open       Date:  2020-04-01       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.